THE REVERSAL OF REJECTION IN HUMAN RENAL HOMOGRAFTS WITH SUBSEQUENT DEVELOPMENT OF HOMOGRAFT TOLERANCE.
作者信息
STARZL T E, MARCHIORO T L, WADDELL W R
出版信息
Surg Gynecol Obstet. 1963 Oct;117:385-95.
Abstract
摘要
相似文献
1
THE REVERSAL OF REJECTION IN HUMAN RENAL HOMOGRAFTS WITH SUBSEQUENT DEVELOPMENT OF HOMOGRAFT TOLERANCE.人类肾移植排斥反应的逆转及随后同种移植耐受性的发展
Surg Gynecol Obstet. 1963 Oct;117:385-95.
2
[CONSIDERATIONS APROPOS OF 4 CASES OF RENAL HOMOGRAFTS].[关于4例肾同种移植的思考]
Acta Chir Belg. 1964 Apr;63:367-85.
3
METABOLIC STUDIES ON RENAL HOMOGRAFT PATIENTS.肾移植患者的代谢研究
J Surg Res. 1965 Aug;5:346-62. doi: 10.1016/s0022-4804(65)80021-x.
4
THE INCIDENCE, CAUSE, AND SIGNIFICANCE OF IMMEDIATE AND DELAYED OLIGURIA OR ANURIA AFTER HUMAN RENAL TRANSPLANTATION.人类肾移植后即刻和延迟性少尿或无尿的发生率、病因及意义
Surg Gynecol Obstet. 1964 Apr;118:819-27.
5
SIXTEEN CASES OF RENAL HOMOTRANSPLANTATION .16例同种肾移植
Arch Intern Med. 1964 Nov;114:601-9. doi: 10.1001/archinte.1964.03860110071004.
6
INFECTIOUS DISEASES ASSOCIATED WITH RENAL HOMOTRANSPLANTATION.与同种肾移植相关的传染病
JAMA. 1964 Aug 10;189:397-407. doi: 10.1001/jama.1964.03070060007001.
7
CLINICAL EXPERIENCE WITH RENAL TRANSPLANTATION.肾移植的临床经验
Br J Urol. 1965 Aug;37:370-9. doi: 10.1111/j.1464-410x.1965.tb09612.x.
8
Prolonged survival of human-kidney homografts by immunosuppressive drug therapy.通过免疫抑制药物疗法延长人肾同种移植的存活时间。
N Engl J Med. 1963 Jun 13;268:1315-23. doi: 10.1056/NEJM196306132682401.
9
CADAVER RENAL HOMOTRANSPLANTS: INITIAL EXPERIENCES.尸体肾同种移植：初步经验
Can Med Assoc J. 1964 Oct 3;91(14):733-42.
10
[FIRST EXPERIENCES IN RENAL TRANSPLANTATION IN HUMANS].[人类肾移植的首次经验]
Gac Med Mex. 1964 Jan;94:93-105.
引用本文的文献
1
Genomic and Biomarker Innovations in Predicting Kidney Transplant Rejection.预测肾移植排斥反应中的基因组和生物标志物创新
J Clin Med. 2025 May 22;14(11):3642. doi: 10.3390/jcm14113642.
2
Immunosuppression Management in Heart Transplantation.心脏移植中的免疫抑制管理
Methodist Debakey Cardiovasc J. 2025 May 15;21(3):40-50. doi: 10.14797/mdcvj.1596. eCollection 2025.
3
Cystatin C is glucocorticoid responsive, directs recruitment of Trem2+ macrophages, and predicts failure of cancer immunotherapy.胱抑素C对糖皮质激素有反应，指导Trem2+巨噬细胞的募集，并预测癌症免疫治疗的失败。
Cell Genom. 2023 Jun 23;3(8):100347. doi: 10.1016/j.xgen.2023.100347. eCollection 2023 Aug 9.
4
The Current State of Donor-Derived Cell-Free DNA Use in Allograft Monitoring in Kidney Transplantation.肾移植中供体来源游离DNA在同种异体移植监测中的应用现状
J Pers Med. 2022 Oct 12;12(10):1700. doi: 10.3390/jpm12101700.
5
Understanding immune perspectives and options for the use of checkpoint immunotherapy in HCC post liver transplant.了解肝移植后肝癌中使用检查点免疫疗法的免疫观点和选择。
Hepatoma Res. 2022;8. doi: 10.20517/2394-5079.2021.123. Epub 2022 Feb 11.
6
Corticosteroids in Immunosuppression.免疫抑制中的皮质类固醇。
Handb Exp Pharmacol. 2022;272:73-84. doi: 10.1007/164_2021_567.
7
The Biology and Molecular Basis of Organ Transplant Rejection.器官移植排斥的生物学和分子基础。
Handb Exp Pharmacol. 2022;272:1-26. doi: 10.1007/164_2021_557.
8
Reconsidering Dexamethasone for Antiemesis when Combining Chemotherapy and Immunotherapy.重新考虑化疗和免疫治疗联合应用时止吐的地塞米松。
Oncologist. 2021 Apr;26(4):269-273. doi: 10.1002/onco.13680. Epub 2021 Feb 26.
9
Autologous cell replacement: a noninvasive AI approach to clinical release testing.自体细胞替换：一种非侵入性人工智能方法用于临床释放测试。
J Clin Invest. 2020 Feb 3;130(2):608-611. doi: 10.1172/JCI133821.
10
Low-dose Rituximab and Thymoglobulin Induction With Steroid-free Maintenance Immunosuppression and Protocol Biopsies Improves Long-term Patient and Graft Survival After Kidney Transplantation: Survival and Safety Outcomes in More Than 1100 Patients From a Single Center.低剂量利妥昔单抗和抗胸腺细胞球蛋白诱导联合无类固醇维持免疫抑制及方案活检可改善肾移植术后患者和移植物的长期存活：来自单一中心1100余例患者的存活及安全性结果
Transplant Direct. 2019 Jul 25;5(8):e475. doi: 10.1097/TXD.0000000000000923. eCollection 2019 Aug.
本文引用的文献
1
Kidney transplantation in modified recipients.改良受体的肾移植
Ann Surg. 1962 Sep;156(3):337-55. doi: 10.1097/00000658-196209000-00002.
2
THE ROLE OF ADRENOCORTICAL STEROIDS IN REVERSING ESTABLISHED HOMOGRAFT REJECTION.肾上腺皮质类固醇在逆转已确立的同种移植排斥反应中的作用。
Surgery. 1964 Mar;55:412-7.
3
TRANSPLANTATION OF THE KIDNEY, SPRING 1963.
Urol Surv. 1963 Dec;13:229-48.
4
EXTRACORPOREAL PERFUSION FOR OBTAINING POSTMORTEM HOMOGRAFTS.用于获取尸源同种移植物的体外灌注
Surgery. 1963 Dec;54:900-11.
5
RENAL HOMOTRANSPLANTATION IN MAN IN MODIFIED RECIPIENTS.人类改良受体中的肾脏同种移植
Ann Surg. 1963 Oct;158(4):608-44. doi: 10.1097/00000658-196310000-00010.
6
A study of the effects of drugs in prolonging survival of homologous renal transplants in dogs.
Ann N Y Acad Sci. 1962 Oct 24;99:743-61. doi: 10.1111/j.1749-6632.1962.tb45358.x.
7
Renal transplantation in identical twins.同卵双胞胎间的肾移植
Arch Surg. 1963 Apr;86:600-7. doi: 10.1001/archsurg.1963.01310100084013.
8
Human renal transplantation. I. Clinical experiences with six cases of renal homotransplantation.人类肾移植。一、6例同种肾移植的临床经验。
J Urol. 1963 Jan;89:13-24. doi: 10.1016/S0022-5347(17)64491-4.
9
Prolonged survival of human-kidney homografts by immunosuppressive drug therapy.通过免疫抑制药物疗法延长人肾同种移植的存活时间。
N Engl J Med. 1963 Jun 13;268:1315-23. doi: 10.1056/NEJM196306132682401.
10
Surgical management of fifty patients with kidney transplants including eighteen pairs of twins.50例肾移植患者的手术管理，其中包括18对双胞胎。
Am J Surg. 1963 Feb;105:205-18. doi: 10.1016/0002-9610(63)90292-7.
Zotero 插件